Ferone D - Search Results

1

"Present and future of immunotherapy in Neuroendocrine Tumors".

Albertelli M, Dotto A, Nista F, Veresani A, Patti L, Gay S, Sciallero S, Boschetti M, Ferone D. Albertelli M, et al. Among authors: ferone d. Rev Endocr Metab Disord. 2021 Sep;22(3):615-636. doi: 10.1007/s11154-021-09647-z. Epub 2021 Apr 14. Rev Endocr Metab Disord. 2021. PMID: 33851319 Free PMC article. Review.

2

Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.

Minuto F, Resmini E, Boschetti M, Arvigo M, Sormani MP, Giusti M, Ferone D, Barreca A. Minuto F, et al. Among authors: ferone d. Clin Endocrinol (Oxf). 2004 Jul;61(1):138-44. doi: 10.1111/j.1365-2265.2004.02064.x. Clin Endocrinol (Oxf). 2004. PMID: 15212656

3

Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR.

Resmini E, Murialdo G, Giusti M, Boschetti M, Minuto F, Ferone D. Resmini E, et al. Among authors: ferone d. J Endocrinol Invest. 2005 Feb;28(2):166-9. doi: 10.1007/BF03345361. J Endocrinol Invest. 2005. PMID: 15887864

4

Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.

Ferone D, Arvigo M, Semino C, Jaquet P, Saveanu A, Taylor JE, Moreau JP, Culler MD, Albertelli M, Minuto F, Barreca A. Ferone D, et al. Am J Physiol Endocrinol Metab. 2005 Dec;289(6):E1044-50. doi: 10.1152/ajpendo.00209.2005. Epub 2005 Jul 26. Am J Physiol Endocrinol Metab. 2005. PMID: 16046458 Free article.

5

Initial staging of lymphoma with octreotide and other receptor imaging agents.

Ferone D, Semino C, Boschetti M, Cascini GL, Minuto F, Lastoria S. Ferone D, et al. Semin Nucl Med. 2005 Jul;35(3):176-85. doi: 10.1053/j.semnuclmed.2005.03.001. Semin Nucl Med. 2005. PMID: 16098291 Review.

6

Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.

Ferone D, Resmini E, Boschetti M, Arvigo M, Albanese V, Ceresola E, Pivonello R, Albertelli M, Bianchi F, Giusti M, Minuto F. Ferone D, et al. J Endocrinol Invest. 2005;28(11 Suppl International):111-7. J Endocrinol Invest. 2005. PMID: 16625859 Review.

7

Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease.

Boschetti M, De Lucchi M, Giusti M, Spena C, Corallo G, Goglia U, Ceresola E, Resmini E, Vera L, Minuto F, Ferone D. Boschetti M, et al. Among authors: ferone d. Eur J Endocrinol. 2006 Jun;154(6):813-8. doi: 10.1530/eje.1.02161. Eur J Endocrinol. 2006. PMID: 16728540

8

Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.

Ferone D, Boschetti M, Resmini E, Giusti M, Albanese V, Goglia U, Albertelli M, Vera L, Bianchi F, Minuto F. Ferone D, et al. Ann N Y Acad Sci. 2006 Jun;1069:129-44. doi: 10.1196/annals.1351.011. Ann N Y Acad Sci. 2006. PMID: 16855140 Review.

9

Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas.

Ferone D, Pivonello R, Resmini E, Boschetti M, Rebora A, Albertelli M, Albanese V, Colao A, Culler MD, Minuto F. Ferone D, et al. Eur J Endocrinol. 2007 Apr;156 Suppl 1:S37-S43. doi: 10.1530/eje.1.02351. Eur J Endocrinol. 2007. PMID: 17413187 Review.

10

Replacement therapy and cardiovascular diseases.

Boschetti M, Goglia U, Teti C, Esposito D, Giusti M, Minuto F, Ferone D. Boschetti M, et al. Among authors: ferone d. J Endocrinol Invest. 2008 Sep;31(9 Suppl):85-90. J Endocrinol Invest. 2008. PMID: 19020394 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page